OpenVSafe by OpenVAERS
Search V-safe

654-28965-30686

2 vaccinations 4 coded responses 12 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
961 / CA
Registered
2021-03-05
Relationship
Self
Race
N/A
Ethnicity
N/A

Timeline

  1. 2021-02-01
    Dose 1 — Moderna
  2. 2021-03-01
    Dose 2 — Moderna
  3. 2021-03-05
    Registered in v-safe
  4. 2021-03-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Rash, not including the immediate area around the injection site
    Adult check-in
  5. 2021-03-06
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site bruising, Injection site erythema, Injection site pruritus, Injection site rash — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Free text: Large bruise (2 inch diameter) at injection site, red itchy rash from mid upper arm wrapping around nicely down to elbow
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-07
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site bruising — Feeling: Good · Fatigue or tiredness
    Free text: Large 2 inch diameter bruise at injection site persists
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-08
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Itching · Fatigue or tiredness
    Adult check-in
  8. 2021-03-15
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-03-22
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-03-31
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-04-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-31
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-08-30
    Survey response — 6 months, dose 2
    MedDRA: Cough, Dysphonia, Fatigue, Headache, Smoke sensitivity — Feeling: Fair · Be unable to do your normal daily activities
    Free text: New onset on 8/28 for two days of headache, cough, fatigue, hoarse voice. We are also in (b)(6) region experiencing heavy fire smoke so hard to know if smoke exposure or illness. Fatigue and hoarse voice have continued to present.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  15. 2022-03-01
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Myalgia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: COVID in January, with post COVID muscle aches that are mostly resolved but reoccur if I get run down
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-02-01Moderna
22021-03-01Moderna

Free text

Release 5 — days 1–6 daily, dose 2

2021-03-06

Systemic reaction (other): Large bruise (2 inch diameter) at injection site, red itchy rash from mid upper arm wrapping around nicely down to elbow

2021-03-07

Systemic reaction (other): Large 2 inch diameter bruise at injection site persists

Release 9 — 6 months, dose 2

2021-08-30

Symptoms: New onset on 8/28 for two days of headache, cough, fatigue, hoarse voice. We are also in (b)(6) region experiencing heavy fire smoke so hard to know if smoke exposure or illness. Fatigue and hoarse voice have continued to present.
redacted (b)(6)

Release 11 — 12 months, dose 2

2022-03-01

Symptoms: COVID in January, with post COVID muscle aches that are mostly resolved but reoccur if I get run down

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough ✓ · ✓
SDCOVID-19 · · ✓
SDDysphonia ✓ · ✓
SDFatigue ✓ · ✓
SDHeadache ✓ · ✓
SDMyalgia · · ✓
SDSmoke sensitivity ✓ · ✓
SROInjection site bruising ✓ ✓ ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site pruritus ✓ ✓ ✓
SROInjection site rash ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release